Prospective Multicenter Registry of Patients With Mitral Stenosis Undergoing Percutaneous Mitral Balloon Commissurotomy

NCT07175532 · tracked via the Priya Life Science South Korea tracker

Sponsor

Asan Medical Center

Phase

Observational

Started

2025-05-01

Last updated

2025-09-16

Condition(s) studied

Mitral Stenosis

Study summary

The goal of this observational study is to learn about the clinical outcomes after percutaneous mitral balloon commissurotomy (PMBC) for patients with mitral stenosis (MS) using nation-wide multicenter prospective registry including tertiary-referral hospitals in Korea.

The main question it aims to answer is:

What is the clinical outcomes after PMBC? Which method is appropriate to determine inflated Inoue balloon size?

Eligibility

Sex

ALL

Min age

18 Years

Max age

89 Years

Healthy volunteers

Inclusion Criteria: * Patients with mitral stenosis undergoing PMBC Exclusion Criteria: * Patients who cannot understand this study due to mental illness * Serious comorbidity limiting life expectancy within 1 year * Limited activity (NYHA class III or IV) due to non-cardiac disease

Primary outcome measure(s)

Number of Participants with Treatment-Related Adverse Events — From enrollment to 1 year after PMBC

Trial sites (1)

Facility	City	Region	Status
Asan Medical Center	Seoul	South Korea	Recruiting

More Asan Medical Center trials in South Korea

CyFluATG in Lower Risk MDS Active, not recruiting

Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke Starting soon

Lenvatinib in Combination With Nivolumab Plus Chemotherapy in Metastatic Gastric Cancer Patients With Malignant Ascites Recruiting

Abbreviated MRI Using Gadoxetic Acid Versus Ultrasonography for Surveillance of Early-stage HCC in Patients at High Risk Active, not recruiting

Efficacy and Safety of Formulation Switching Between SC Infliximab and IV Infliximab in Patients With CD Recruiting

Other trials for the same condition

Mild ANH on Pre-bypass Coagulation Function During Cardiac Surgery Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07175532 on ClinicalTrials.gov ↗ ← All trials in South Korea